Natasha A. D.
- Country
- The Netherlands
- Department
- Center for Bone Quality
Research Overview
- Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study of AGA2115, a Humanised IgG4 Bispecific Anti‑Sclerostin/DKK1 Antibody, in Adults with Osteogenesis Imperfecta
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Eneboparatide (AZP-3601) Efficacy and Safety in Chronic Hypoparathyroidism Patients
- Evaluation of Denosumab in the Management of Fibrous Dysplasia/McCune-Albright Syndrome in Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 3 of 34 partner sites.
Specializations
Bone and Mineral Disorders
This investigator specializes in treating complex bone conditions, with particular focus on Fibrous Dysplasia and McCune-Albright Syndrome. Their research explores innovative therapeutic approaches for managing bone pain and structural abnormalities.
- Bone Pain Management
- Skeletal Disease Treatment
- Bone Density Regulation
Endocrine Disorders
The investigator focuses on treating chronic hypoparathyroidism, exploring novel therapeutic agents to regulate calcium metabolism and improve patient outcomes. Their work involves evaluating treatments that affect parathyroid hormone function.
- Calcium Homeostasis
- Vitamin D Metabolism
- Hormone Replacement Therapy
Post-Surgical Endocrine Complications
The investigator studies secondary hyperparathyroidism following bariatric procedures, with particular attention to vitamin D metabolism and its role in maintaining mineral homeostasis after gastric bypass surgery.
- Bariatric Surgery Complications
- Metabolic Bone Disease
- Mineral Supplementation Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.